• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Life Sciences
  • Investments
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage

AbilTo Launches Tele-Behavioral Program for Substance Use

by Jasmine Pennic 01/20/2016 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

AbilTo

AbilTo, Inc., a provider of evidence-based behavioral change programs proven to improve medical health and lower cost for high-cost medical populations has announced the addition of its Depression and Substance Use program. The new program helps individuals understand the interaction between mood and substance use, and identify strategies to replace use with positive coping skills and healthy reinforcement. 

AbilTo’s Depression and Substance Use program helps participants focus on specific behaviors that influence depression and use. Participants receive non-judgmental, personalized support to modify negative behaviors and practice effective coping skills. They learn to clearly articulate their goals and find ways to increase their self-motivation and efficacy, through a deeper confidence in their ability to change. As with AbilTo’s other program offerings, licensed clinical social workers and behavior coaches provide treatment by telephone or secure video.

The National Institute on Drug Abuse has attributed $166 billion to the cost of healthcare resulting from the abuse of tobacco, alcohol and other drugs. Among those individuals with substance use disorders, sixty percent also suffer from depression. Studies have shown that behavioral change programs, such as those administered by AbilTo, can measurably reduce the cost of care and improve outcomes for these individuals.

“Behavior change, for those who suffer from substance use and depression, can be challenging,” said Aimee Peters, LCSW, chief clinical officer, AbilTo. “Our program acknowledges that the journey toward change is different for each individual, and our providers tailor their approach accordingly. This enables participants to set unique, achievable goals that get them back on the path to happier, healthier and more productive lives.”

The company recently raised $12M in Series C funding last year led by  HLM Venture Partners (HLM) and Yumin Choi, Partner along with previous investors BlueCross BlueShield Venture Partners, .406 Ventures and Sandbox Industries. 

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: AbilTo

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

2026 Predictions & Trends

Healthcare 2026 Forecast: Executives on AI Survival, Financial Reckoning, and the End of Point Solutions

2026 Healthcare Executive Predictions: Why the AI “Pilot Era” Is Officially Over

Most-Read

HHS Launches 'OneHHS' AI Strategy to Integrate AI Across CDC, CMS, and FDA for Efficiency and Public Trust

HHS Launches ‘OneHHS’ AI Strategy to Integrate AI Across CDC, CMS, and FDA for Efficiency and Public Trust

Kristen Hartsell, VP of Clinical Services, RedSail Technologies

The Pharmacy Closures Crisis: How Independent Pharmacies Are Fixing Pharmacy Deserts

From Overwhelmed to Optimized: How AI Agents Address Staffing Challenges and Burnout in Healthcare

From Overwhelmed to Optimized: How AI Agents Address Staffing Challenges and Burnout in Healthcare

The VBC Paradox: Why Hospitals Are Doubling Down on Value-Based Care While Revenue at Risk Lags

The VBC Paradox: Why Hospitals Are Doubling Down on Value-Based Care While Revenue at Risk Lags

Tebra Secures $250M to Challenge Legacy EHRs with AI-Powered Automation

Tebra Secures $250M to Challenge Legacy EHRs with AI-Powered Automation

AstraZeneca Selects Salesforce Agentforce Life Sciences to Deploy AI-Powered Global Customer Engagement

AstraZeneca Selects Salesforce Agentforce Life Sciences to Deploy AI-Powered Global Customer Engagement

Aidoc Partners with NVIDIA MONAI to Scale Open-Source Clinical AI

Aidoc Partners with NVIDIA MONAI to Scale Open-Source Clinical AI

RapidAI Secures FDA Clearance for Five New Deep Clinical AI Modules, Expanding Enterprise Imaging Platform

RapidAI and AWS Deepen Partnership to Scale Clinical AI in Healthcare

Greece and Sword Health to Build AI-Powered Healthcare Front Door

Greece and Sword Health to Build AI-Powered Healthcare Front Door

GE HealthCare Acquires Intelerad for $2.3B to Create Cloud-First, AI-Enabled Imaging Ecosystem

GE HealthCare Acquires Intelerad for $2.3B to Create Cloud-First, AI-Enabled Imaging Ecosystem

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Op-Ed Submission Guidelines
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |